Hematopoietic Subsyndrome of Acute Radiation Syndrome (DBCOND0020289)
Identifiers
- Synonyms
- Acute Radiation Syndrome / Hematopoietic Syndrome Due to Acute Radiation Syndrome / Hematopoietic subsyndrome of acute radiation syndrome / Acute radiation sickness / Acute radiation syndrome (disorder) / Hematopoietic subsyndrome of acute radiation syndrome (disorder) / Radiation sickness syndrome
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Filgrastim A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy.Pegfilgrastim A recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy.Sargramostim A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant.- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT02587442 A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers No drug interventions prevention 1 unknown_status NCT04650555 BIO 300 Oral Powder Safety and Pharmacokinetics prevention 1 completed NCT03585803 A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011 No drug interventions treatment 1 completed NCT00504335 Safety and Pharmacokinetic Study of BIO 300 Capsules treatment 1 completed NCT00903929 Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation treatment 1 completed NCT02343133 Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome treatment 2 completed NCT01742221 Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure treatment 1 completed